日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Preclinical concept studies showing advantage of an inhaled anti-CTGF/CCN2 protein for pulmonary fibrosis treatment.

临床前概念研究表明吸入抗 CTGF/CCN2 蛋白在治疗肺纤维化方面具有优势

Neiens Vanessa, Hansbauer Eva-Maria, Jaquin Thomas J, Peper-Gabriel Janet K, Mahavadi Poornima, Snyder Mark E, Grill Maximilian J, Wurzenberger Cornelia, Konitsiotis Antonio, Estrada-Bernal Adriana, Heinig Kristina, Fysikopoulos Athanasios, Schwenck Nicolas, Grüner Stefan, Bartoschek Denis, Mosebach Theresia, Kerstan Sandra, Wrennall Joe, Richter Marleen, Noda Kentaro, Hoetzenecker Konrad, Burgess Janette K, Tarran Robert, Wurzenberger Claudia, Wichmann Karl-Robert, Biehler Jonas, Müller Kei W, Guenther Andreas, Eickelberg Oliver, Fitzgerald Mary F, Olwill Shane A, Matschiner Gabriele, Pavlidou Marina

A First-in-Human Study of Cinrebafusp Alfa, a HER2/4-1BB Bispecific Molecule, in Patients with HER2-Positive Advanced Solid Malignancies

Cinrebafusp Alfa(一种 HER2/4-1BB 双特异性分子)在 HER2 阳性晚期实体恶性肿瘤患者中的首次人体研究

Piha-Paul, Sarina; Olwill, Shane A; Hamilton, Erika; Tolcher, Anthony; Pohlmann, Paula; Liu, Stephen V; Wurzenberger, Cornelia; Hasenkamp, Laura-Carolin; Hansbauer, Eva-Maria; Shroff, Rachna; Hurvitz, Sara; Krishnamurthy, Anuradha; Patnaik, Amita; Hahn, Noah; Kumar, Raman; Duerr, Manuela; Zettl, Markus; Aviano, Kayti; Matis, Louis; Bruns, Ingmar; Ku, Geoffrey

Pulmonary-delivered Anticalin Jagged-1 antagonists reduce experimental airway mucus hyperproduction and obstruction.

肺部给药的 Anticalin Jagged-1 拮抗剂可减少实验性气道粘液过度产生和阻塞

Heinzelmann Katharina, Fysikopoulos Athanasios, Jaquin Thomas J, Peper-Gabriel Janet K, Hansbauer Eva-Maria, Grüner Stefan, Prassler Josef, Wurzenberger Claudia, Kennedy Joseph G C, Snead Jazmin Y, Wrennall Joe A, Heinig Kristina, Wurzenberger Cornelia, Bel Aiba Rachida-Siham, Tarran Robert, Livraghi-Butrico Alessandra, Fitzgerald Mary F, Anderson Gary P, Rothe Christine, Matschiner Gabriele, Olwill Shane A, Hagner Matthias